EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Burosumab for X-linked Hypophosphataemia and Tumour-induced Osteomalacia in Adults

Simon Black, Richard Keen, Judith Bubbear

touchREVIEWS in Endocrinology · 2026-05 · 22 (1)

DOI: 10.17925/ee.2026.22.1.6 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift touchREVIEWS in Endocrinology, 2026-05. Verfasst von Simon Black und 2 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Bone Disease Centre, Royal National Orthopaedic Hospital, Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, Middlesex, UK. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

BurosumabX-linked hypophosphataemiafibroblast growth factor (FGF)-23hypophosphataemiaosteomalaciaricketstumour-induced osteomalacia

Autor:innen und Institutionen

  • Metabolic Bone Disease Centre, Royal National Orthopaedic Hospital, Royal National Orthopaedic Hospital, Brockley Hill, Stanmore, Middlesex, UK.

Zitieren

APA

Black, S., Keen, R., & Bubbear, J. (2026). Burosumab for X-linked Hypophosphataemia and Tumour-induced Osteomalacia in Adults. touchREVIEWS in Endocrinology, 22(1). https://doi.org/10.17925/ee.2026.22.1.6

Vancouver

Black S, Keen R, Bubbear J. Burosumab for X-linked Hypophosphataemia and Tumour-induced Osteomalacia in Adults. touchREVIEWS in Endocrinology. 2026;22(1). doi:10.17925/ee.2026.22.1.6

BibTeX
@article{Black2026,
  author = {Black, Simon and Keen, Richard and Bubbear, Judith},
  title = {Burosumab for X-linked Hypophosphataemia and Tumour-induced Osteomalacia in Adults},
  journal = {touchREVIEWS in Endocrinology},
  year = {2026},
  volume = {22},
  number = {1},
  doi = {10.17925/ee.2026.22.1.6}
}
Kostenlos starten →